Kotra Industries Stock

Equities

KOTRA

MYQ0002OO004

Pharmaceuticals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
4.66 MYR -0.85% Intraday chart for Kotra Industries -0.85% -3.52%
Sales 2024 * 252M 52.8M Sales 2025 * 270M 56.61M Capitalization 691M 145M
Net income 2024 * 55M 11.51M Net income 2025 * 59M 12.35M EV / Sales 2024 * 2.74 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.56 x
P/E ratio 2024 *
12.4 x
P/E ratio 2025 *
11.6 x
Employees -
Yield 2024 *
4.69%
Yield 2025 *
4.76%
Free-Float 17.34%
More Fundamentals * Assessed data
Dynamic Chart
Kotra Industries Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 21 March 2024 CI
Kotra Industries Berhad Reports Written Off Results for the Second Quarter Ended December 31, 2023 CI
Kotra Industries Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Kotra Industries Posts Lower Profit, Revenue in Fiscal Q1 MT
Kotra Industries Berhad Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Kotra Industries to Seek Shareholders' Nod to Renew Transactions Authority MT
Kotra Industries to Pay Dividend Despite Profit Drop in Fiscal Q4 MT
Kotra Industries Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023 CI
Kotra Industries Berhad Announces Second Interim Dividend for the Financial Year Ended 30 June 2023, Payable on 12 October 2023 CI
Kotra Industries Profit Edges Up in Fiscal Q3 MT
Kotra Industries Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Kotra Industries Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Kotra Industries Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 30 June 2023, Payable 23 March 2023 CI
Kotra Industries Berhad Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Kotra Industries Berhad Announces Single Tier Final Dividend for the Financial Year Ended 30 June 2022, Payable on 08 December 2022 CI
More news
1 day-0.85%
1 week-0.85%
1 month-0.85%
3 months-2.92%
6 months-9.34%
Current year-3.52%
More quotes
1 week
4.62
Extreme 4.62
4.70
1 month
4.62
Extreme 4.62
4.79
Current year
4.58
Extreme 4.58
5.12
1 year
4.47
Extreme 4.47
5.78
3 years
2.25
Extreme 2.25
6.97
5 years
1.60
Extreme 1.6
6.97
10 years
0.92
Extreme 0.92
6.97
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 00-06-04
Director of Finance/CFO 50 03-06-30
Chief Operating Officer 53 05-10-31
Members of the board TitleAgeSince
Chairman 63 17-01-01
Chief Executive Officer 66 00-06-04
Director/Board Member 57 00-06-04
More insiders
Date Price Change Volume
24-04-19 4.66 -0.85% 9,000
24-04-18 4.7 0.00% 27,100
24-04-17 4.7 +0.43% 26,300
24-04-16 4.68 -0.43% 18,800

End-of-day quote BURSA MALAYSIA, April 18, 2024

More quotes
Kotra Industries Berhad is a Malaysia-based company, which is engaged in investment holding and the provision of management. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd., is engaged in developing, manufacturing and supplying of pharmaceutical and healthcare products. The Company offers a range of healthcare products of over-the-counter (OTC) supplements, nutritional products as well as pharmaceutical products in various dosage forms. The Company's brands include Appeton, Axcel, Vaxcel and Arite. The Appeton brand offers OTC products that cater to all stages of life, from prenatal development needs to geriatric health supplements. The Axcel brand specializes in pediatric care, anti-infective medicine and dermatological care. The Vaxcel branded products are focused on sterile injectables that feature a range of antibiotics to treat a range of health conditions. The Company's metered dose inhalers are branded as Arite.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.66 MYR
Average target price
5.497 MYR
Spread / Average Target
+17.95%
Consensus

Annual profits - Rate of surprise